-
1.HETEROARYL ACID MORPHOLINONE COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: 杂芳基酸吗啉酮化合物作为MDM2抑制剂治疗癌症公开(公告)号:EP2970237B1
公开(公告)日:2017-09-27
申请号:EP14716176.4
申请日:2014-03-13
申请人: Amgen Inc.
IPC分类号: C07D413/06 , C07D417/06 , A61K31/5377 , A61P35/00
CPC分类号: C07D265/32 , C07D413/06 , C07D417/06
-
2.PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: PIPERIDINONDERIVATE ALS MDM2-HEMMER ZUR KREBSBEHANDLUNG公开(公告)号:EP2576510B1
公开(公告)日:2015-04-29
申请号:EP11726581.9
申请日:2011-06-03
申请人: Amgen Inc.
发明人: BARTBERGER, Michael David , GONZALEZ BUENROSTRO, Ana , BECK, Hilary Plake , CHEN, Xiaoqi , CONNORS, Richard Victor , DEIGNAN, Jeffrey , DUQUETTE, Jason , EKSTEROWICZ, John , FISHER, Benjamin , FOX, Brian Matthew , FU, Jiasheng , FU, Zice , GONZALEZ LOPEZ DE TURISO, Felix , GRIBBLE, JR., Michael William , GUSTIN, Darin James , HEATH, Julie Anne , HUANG, Xin , JIAO, Xianyun , JOHNSON, Michael , KAYSER, Frank , KOPECKY, David John , LAI, Sujen , LI, Yihong , LI, Zhihong , LIU, Jiwen , LOW, Jonathan Dante , LUCAS, Brian Stuart , MA, Zhihua , MCGEE, Lawrence , MCINTOSH, Joel , MCMINN, Dustin , MEDINA, Julio Cesar , MIHALIC, Jeffrey Thomas , OLSON, Steven Howard , REW, Yosup , ROVETO, Philip Marley , SUN, Daqing , WANG, Xiaodong , WANG, Yingcai , YAN, Xuelei , YU, Ming , ZHU, Jiang
IPC分类号: C07D211/40 , C07D401/04 , C07D401/06 , C07D407/04 , C07D407/06 , C07D409/04 , C07D413/06 , C07D417/06 , C07D471/20 , C07D279/02 , C07D401/12 , C07D498/08 , C07D498/20 , A61K31/4412 , A61P35/00
CPC分类号: C07D211/76 , C07D221/20 , C07D279/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/06 , C07D409/04 , C07D409/12 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/10 , C07D491/08 , C07D491/153 , C07D498/08 , C07D498/14 , C07D498/20
-
3.PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: PIPERIDINONDERIVATE AS MDM2抑制剂用于癌症治疗公开(公告)号:EP2576510A1
公开(公告)日:2013-04-10
申请号:EP11726581.9
申请日:2011-06-03
申请人: Amgen Inc.
发明人: BARTBERGER, Michael David , GONZALEZ BUENROSTRO, Ana , BECK, Hilary Plake , CHEN, Xiaoqi , CONNORS, Richard Victor , DEIGNAN, Jeffrey , DUQUETTE, Jason , EKSTEROWICZ, John , FISHER, Benjamin , FOX, Brian Matthew , FU, Jiasheng , FU, Zice , GONZALEZ LOPEZ DE TURISO, Felix , GRIBBLE, JR., Michael William , GUSTIN, Darin James , HEATH, Julie Anne , HUANG, Xin , JIAO, Xianyun , JOHNSON, Michael , KAYSER, Frank , KOPECKY, David John , LAI, Sujen , LI, Yihong , LI, Zhihong , LIU, Jiwen , LOW, Jonathan Dante , LUCAS, Brian Stuart , MA, Zhihua , MCGEE, Lawrence , MCINTOSH, Joel , MCMINN, Dustin , MEDINA, Julio Cesar , MIHALIC, Jeffrey Thomas , OLSON, Steven Howard , REW, Yosup , ROVETO, Philip Marley , SUN, Daqing , WANG, Xiaodong , WANG, Yingcai , YAN, Xuelei , YU, Ming , ZHU, Jiang
IPC分类号: C07D211/40 , C07D401/04 , C07D401/06 , C07D407/04 , C07D407/06 , C07D409/04 , C07D413/06 , C07D417/06 , C07D471/20 , C07D279/02 , C07D401/12 , C07D498/08 , C07D498/20 , A61K31/4412 , A61P35/00
CPC分类号: C07D211/76 , C07D221/20 , C07D279/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/06 , C07D409/04 , C07D409/12 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/10 , C07D491/08 , C07D491/153 , C07D498/08 , C07D498/14 , C07D498/20
摘要: The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
-
4.
公开(公告)号:EP3762393A1
公开(公告)日:2021-01-13
申请号:EP19714512.1
申请日:2019-03-04
申请人: Amgen Inc.
发明人: RESCOURIO, Gwenaella , GONZALEZ BUENROSTRO, Ana , BROWN, Sean P. , LIZARZABURU, Mike , MEDINA, Julio C. , JABRI, Salman Yojiro , SUN, Daqing , SIMONOVICH, Scott Preston , YAN, Xuelei , LI, Yihong , REW, Yosup
IPC分类号: C07D498/10 , C07D498/20 , A61P35/00 , A61K31/553 , C07D498/22
-
公开(公告)号:EP3186259A1
公开(公告)日:2017-07-05
申请号:EP15772048.3
申请日:2015-08-28
申请人: Amgen Inc.
发明人: BROWN, Sean P. , LI, Yunxiao , LIZARZABURU, Mike Elias , LUCAS, Brian S. , PARAS, Nick A. , TAYGERLY, Joshua , VIMOLRATANA, Marc , WANG, Xianghong , YU, Ming , ZANCANELLA, Manuel , ZHU, Liusheng , GONZALEZ BUENROSTRO, Ana , LI, Zhihong
IPC分类号: C07D513/08 , A61K31/554 , A61P35/00
CPC分类号: C07D513/10 , C07D513/08
摘要: Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
摘要翻译: 及其药学上可接受的盐和含有该化合物的药物组合物。 本文提供的化合物和组合物可以用于例如治疗疾病或病症如癌症。
-
6.HETEROARYL ACID MORPHOLINONE COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: CIS-MORPHOLINON UND ANDERE VERBINDUNGEN ALS MDM2-INHIBITOREN ZUR BEHANDLUNG VON KREBS公开(公告)号:EP2970237A1
公开(公告)日:2016-01-20
申请号:EP14716176.4
申请日:2014-03-13
申请人: Amgen Inc.
IPC分类号: C07D413/06 , C07D417/06 , A61K31/5377 , A61P35/00
CPC分类号: C07D265/32 , C07D413/06 , C07D417/06
摘要: The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor of Formula (I).
摘要翻译: 本发明提供式(I)的MDM2抑制剂化合物或其药学上可接受的盐,其中变量如上所定义,哪些化合物可用作治疗剂,特别是用于治疗癌症。 本发明还涉及含有式(I)的MDM2抑制剂的药物组合物。
-
-
-
-
-